Gall stone causes

Reading File

Finding Sources

Searching PubMed

gallstone cholelithiasis pathogenesis risk factors

Reading File

Loading Image

Here is a thorough, textbook-based explanation of gallstone causes.

Gallstones (Cholelithiasis) - Causes & Pathogenesis

Gallstones affect 10-20% of adults in Western countries, with roughly 1 million new cases diagnosed annually in the US alone. There are two main types, each with distinct causes.

Cholesterol gallstones in an opened gallbladder with thickened, fibrotic wall from chronic cholecystitis

Cholesterol gallstones in an opened gallbladder. The wall is thickened and fibrotic from chronic cholecystitis. (Robbins & Kumar Basic Pathology)

Type 1: Cholesterol Stones (80% in Western countries)

Core Mechanism

Bile is the body's only significant route for eliminating excess cholesterol, either as free cholesterol or as bile salts. Cholesterol is kept water-soluble by aggregation with bile salts and lecithins. When cholesterol exceeds the solubilizing capacity of bile (supersaturation), it can no longer stay dispersed and crystallizes out of solution. Gallbladder hypomotility (stasis) then promotes crystal nucleation, and mucus hypersecretion traps crystals, encouraging their aggregation into stones.

Risk Factors for Cholesterol Stones

Risk Factor	Mechanism
Age	Prevalence < 5% under 40 years; rises to 25-30% over 80 years
Female sex	Women are twice as likely as men at all ages
Estrogen / Female hormones	Estrogens increase hepatic cholesterol uptake and synthesis, causing excess biliary secretion of cholesterol
Oral contraceptives	Same estrogen-driven mechanism
Pregnancy	Elevated estrogen + progesterone-induced gallbladder stasis
Obesity & metabolic syndrome	Strongly associated with increased biliary cholesterol secretion
Rapid weight loss	Increases hepatic cholesterol output into bile
Gallbladder stasis / hypomotility	Seen with prolonged fasting, total parenteral nutrition (TPN), pregnancy, diabetes, and spinal cord injury - promotes crystal nucleation
Inborn disorders of bile acid metabolism	Impaired synthesis or secretion of bile salts reduces cholesterol solubilization
Dyslipidemia syndromes	Elevated plasma cholesterol increases biliary cholesterol
Heredity	~25% of cholelithiasis risk is genetic; family history significantly raises risk

Notable ethnic predisposition: Native Americans (Pima, Hopi, Navajo) have a prevalence approaching 50%, while Asian populations have much lower rates (3-4%).

Type 2: Pigment Stones (predominant in non-Western populations)

Core Mechanism

Pigment stones are made up of insoluble calcium bilirubinate salts. They form when bile contains a high concentration of unconjugated bilirubin. Unconjugated bilirubin precipitates with calcium to form these stones.

Risk Factors for Pigment Stones

Risk Factor	Mechanism
Chronic hemolytic anemias (sickle cell disease, hereditary spherocytosis, thalassemia)	Increased red cell destruction generates excess unconjugated bilirubin
Biliary tract infections (liver flukes - Clonorchis sinensis, bacterial cholangitis)	Bacterial glucuronidases hydrolyze conjugated bilirubin back to unconjugated form
Cirrhosis	Reduced bile salt synthesis impairs solubilization of bilirubin
Crohn disease (ileal involvement)	Altered enterohepatic cycling of bilirubin; increased bilirubin concentration in bile
Ileal resection or bypass	Same mechanism as Crohn disease - loss of bile salt reabsorption
Cystic fibrosis with pancreatic insufficiency	Impaired bile acid metabolism and biliary dysfunction

Memory Aid: The "5 F's" of Cholesterol Gallstones

A classic clinical mnemonic for risk factors:

Fat (obesity)
Female
Fertile (pregnancy / oral contraceptives)
Forty (age > 40)
Fair (historically used for higher-risk ethnic groups in Western populations)

Summary Table

Feature	Cholesterol Stones	Pigment Stones
Composition	Crystalline cholesterol monohydrate	Calcium bilirubinate salts
Prevalence in West	80-90%	10-20%
Location	Gallbladder only	Anywhere in biliary tree
Key cause	Bile supersaturation with cholesterol	Excess unconjugated bilirubin
Color	Pale yellow to gray-white	Black (sterile bile) or brown (infected bile)
Radiology	Mostly radiolucent	Black stones 50-75% radiopaque; brown stones radiolucent

Source: Robbins & Kumar Basic Pathology (Robbins Pathology), pp. 630-631

Gall stone paper published regarding Lith 1 or Lith 2 gene in mice

Searching PubMed

Lith1 Lith2 gallstone mice quantitative trait loci

Searching PubMed

gallstone susceptibility gene locus mice lithogenic

Reading Article

I now have a thorough picture of the Lith gene literature. Here is a comprehensive, well-cited summary:

Lith1 and Lith2 Genes in Mouse Gallstone Research

Background

Cholesterol gallstone susceptibility in mice is a complex polygenic trait. The breakthrough in mapping these genes came from crossing gallstone-susceptible and gallstone-resistant inbred mouse strains on a lithogenic diet (1% cholesterol + 0.5% cholic acid + 15% butterfat), then using Quantitative Trait Locus (QTL) analysis to identify chromosomal regions linked to stone formation.

The Landmark Lith1 and Lith2 Discovery Paper

Paigen B, Schork NJ, Svenson KL, et al. (2000) "Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice." Physiological Genomics. PMID: 11074014

This is the primary paper that identified and named Lith1 and Lith2:

Cross used: Gallstone-susceptible C57L/J × gallstone-resistant AKR/J - backcross of 231 male F1 × AKR mice
Diet: Lithogenic diet for 8 weeks; mice were genotyped at ~20 cM intervals
Lith1: Mapped near marker D2Mit56 on chromosome 2 - the major locus; confirmed by constructing a congenic strain AK.L-Lith1s
Lith2: Mapped near marker D19Mit58 on chromosome 19 - confirmed by congenic strain AK.L-Lith2s
Additional suggestive loci were found on chromosomes 6, 7, 8, 10, and X

Expansion of the Lith Gene Map (Lith1 through Lith5+)

Wittenburg H, Lyons MA, Paigen B, Carey MC (2003) "Mapping cholesterol gallstone susceptibility (Lith) genes in inbred mice." Digestive and Liver Disease. PMID: 12974501

This review summarized progress through the first five Lith loci (Lith1-Lith5) and outlined the QTL-to-gene pipeline:

QTL mapping in susceptible × resistant crosses
Congenic strain construction to confirm loci
Positional cloning of candidate genes
Knockout/knockin mouse validation
Human ortholog identification (mouse-human genome homology is exceptionally close)

Lith Genes Controlling Mucin, Crystallization, and Stone Formation

Lammert F, Wang DQ-H, Wittenburg H, et al. (2002) "Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice." Hepatology. PMID: 12395324

Used A/J × AKR/J cross (225 backcross mice)
Identified Lith3 on chromosome 17
Discovered a mucin locus on chromosome 15 harboring Glycam1 (expressed in gallbladder epithelium) - the first biliary mucin gene linked to a Lith QTL
Showed Lith loci co-localize with QTLs controlling cholesterol crystal formation

FXR and ABCG5/ABCG8 Identified as Lith Gene Candidates

Wittenburg H, Lyons MA, Li R, et al. (2003) "FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice." Gastroenterology. PMID: 12949731

Used PERA/Ei × I/LnJ intercross
Identified Lith7 (chromosome 10) - candidate gene: FXR (Nr1h4, the nuclear bile salt receptor)
Identified Lith8 (chromosome 4) - candidate gene: SHP1 (Nr0b2, small heterodimer partner)
Identified Lith9 (chromosome 17) - colocalizes with ABCG5/ABCG8 (canalicular cholesterol transporter); higher expression in susceptible PERA/Ei mice correlates with higher biliary cholesterol

Comprehensive Review of All Lith Genes

Wang HH, Portincasa P, Afdhal NH, Wang DQ-H (2010) "Lith genes and genetic analysis of cholesterol gallstone formation." Gastroenterology Clinics of North America. PMID: 20478482

This is the most thorough review available, covering:

The full panel of identified Lith genes (Lith1 through ~Lith13+)
QTL analysis methodology
Candidate genes at each locus
Pathway from mouse Lith genes to human LITH gene discovery

Summary Table: Key Lith Loci

Locus	Chromosome	Mouse Strains Used	Candidate Gene(s)	Key Paper
Lith1	Chr 2	C57L/J × AKR/J	Under investigation	Paigen 2000 (PMID 11074014)
Lith2	Chr 19	C57L/J × AKR/J	Under investigation	Paigen 2000 (PMID 11074014)
Lith3	Chr 17	A/J × AKR/J	-	Lammert 2002 (PMID 12395324)
Lith7	Chr 10	PERA/Ei × I/LnJ	FXR (Nr1h4)	Wittenburg 2003 (PMID 12949731)
Lith8	Chr 4	PERA/Ei × I/LnJ	SHP1 (Nr0b2)	Wittenburg 2003 (PMID 12949731)
Lith9	Chr 17	PERA/Ei × I/LnJ	ABCG5/ABCG8	Wittenburg 2005 (PMID 16151694)

Clinical Relevance

The mouse Lith gene program was designed as a "road map" to discover orthologous human LITH genes. Because mouse-human genome homology is very high, once mouse Lith genes are positionally cloned, their human counterparts can be tested in susceptible populations. Notably, human ABCG5/ABCG8 polymorphisms have subsequently been shown to influence gallstone risk, validating this animal-to-human translational approach.

This is a shared conversation. Sign in to Orris to start your own chat.